Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Guidelines for RSV prevention with Nirsevimab

Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract infections in infants and young children. Nirsevimab is a long-acting monoclonal antibody that provides passive immunization against RSV, offering protection throughout the RSV season with a single dose

RSV Shield: WEQAYA's Strategy on Nirsevimab Implementation

This video explains WEQAYA's strategy on Nirsevimab Implementation

RSV Shield: WEQAYA's Strategy on Nirsevimab Implementation

This video explains WEQAYA's strategy on Nirsevimab Implementation

RSV Shield: WEQAYA's Strategy on Nirsevimab Implementation

This video explains WEQAYA's strategy on Nirsevimab Implementation

Immer einen Schritt voraus – mit dem Fachnewsletter von Sanofi

Immer einen Schritt voraus – mit dem Fachnewsletter von Sanofi

Morbus Gaucher - Does your patient have MGUS?

Cerezyme® - Power to the bones. More thant 20 years of therapy experience

Morbus Gaucher: Leukaemia? Your first suspicion may be wrong!

Hội Thảo: Bảo Vệ Cúm Và Hơn Thế Nữa: Dữ Liệu Của Vắc-xin Cúm Mùa Bất Hoạt Dạng Mảnh

Understanding Disease Modification in Atopic Dermatitis

Understanding Disease Modification in Atopic Dermatitis